Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles

Journal of Virology

Volumn 76, Issue 21, 2002, Pages 10905-10913

  Baker, Christopher A ^a   Martin, Daniel ^a   Manuelidis, Laura ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CATHEPSIN B; CHEMOATTRACTANT; CHEMOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; PRION PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN HOMOGENATE; BRAIN INFECTION; BRAIN SPONGIOSIS; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; GENE ACTIVATION; GENE EXPRESSION; HEMATOPOIETIC CELL; INFLAMMATION; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCRAPIE;

AMYLOID BETA-PROTEIN; ANIMALS; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD45; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN; CHEMOKINES, CXC; CREUTZFELDT-JAKOB SYNDROME; GENE EXPRESSION; GENE EXPRESSION PROFILING; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, CCR5; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036838213     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.21.10905-10913.2002     Document Type: Article

References (47)

1. Albright, A. V., J. Martin, M. O'Connor, and F. Gonzalez-Scarano. 2001. Interactions between HIV-1, gp120 chemokines,. and cultured adult microglial cells. J. Neurovirol. 7:196-207.
2. Aucouturier, P., F. Geissmann, D. Darnotte, G. P. Saborio, H. C. Meeker, R. Kascsak, R. I. Carp, and T. Wisniewski. 2001. Infected splenic dendritic cells are sufficient for prion transmission fo to the central nervous system in mouse scrapie. J. Clin. Investig. 108:703-708.
3. Baker, C. A., Z. Y. Lu, I. Zaitsev, and L. Manuelidis. 1999. Microglial activation varies in different models of Creutzfeldt-Jakob disease. J. Virol. 73:5089-5097.
4. Brown, K. L., K. Stewart, D. L. Ritchie, N. A. Mabbott, A, Williams, H. Fraser, W. I, Morrison, and M. E, Bruce, 1999. Scrapie repliction in lymphoid tissues depends on prion protein-expressing follicular dendritic cells, Nat. Med. 5:1308-1312.
5. Campbell, I, L., M. Eddleston, P. Kemper, M. B. A. Oldstone, and M. V. Hobbs, 1994. Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J. Virol. 68:2383-2387.
6. Combs, C. K., D, E. Johnson, S. B. Cannady, T. M. Lehman, and G. E, Landreth, 1999. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J. Neurosci. 19:929-939.
7. Czub, M., H, Braig, and H, Diringer, 1988. Replication of the scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloidinducing virosis. J. Gen. Virol. 69:1753-1756.
8. Du Yan, S., H. Zhu, J. Fu, S. F. Yan, A. Roher, W. W. Tourtellotte, T. Rajavashisth, X. Chen, G. Godman, D. Stern, and A. M. Schmidt. 1997. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 94:5296-5301.
9. Eklund, C. M., R. C. Kennedy, and W. J. Hadlow. 1967. Pathogenesis of scrapie virus infection in the mouse. J. Infect. Dis. 117:15-22.
10. Enari, M., E. Flechsig, and C. Weissmann. 2001. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl. Acad. Sci. USA 98:9295-9299.
11. Fischer, M., T. Rülicke, A. Raeber, A. Sailer, M. Moser, B. Oesch, S. Brandner, A. Aguzzi, and C. Weissman. 1996. Prion protein (PrP) with aminoproximal deletions restoring susceptibility of knockout mice to scrapie. EMBO J. 15:1255-1264.
12. Ford, A. L., A. L. Goodsall, W. F. Hickey, and J. D. Sedgwick. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting: phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared., J. Immunol. 154:4309-4321.
13. Giese, A., D. R. Brown, M. H. Groschup, C. Feldmann, I. Haist, and H. A. Kretzschmar. 1998. Role of microglia in neuronal cell death and prion disease. Brain Pathol. 8:449-457.
14. Goldfarb, L. G., and P. Brown. 1995. The transmissible spongiform encephalopathies. Annu. Rev. Med. 46:57-65.
15. He, J., Y. Chen, M. Farzan, H. Choe, A. Ohagen, S. Gartner, J. Busciglio, X. Yang, W. Hofmann, W. Newman, C. R. Mackay, J. Sodroski, and D. Gabuzda. 1997. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 385:645-649.
16. Hill, A., M. Antoniou, and J. Collinge. 1999. Protease-resistant prion protein produced in vitro lacks detectable infectivity. J. Gen. Virol. 80:11-14.
17. Hua, L. L., and S. C. Lee. 2000. Distinct patterns of stimulus-inducible chemokine mRNA accumulation in human fetal astrocytes and microglia. Glia 30:74-81.
18. Kordek, R., V. R. Nerurkar, P. P. Liberski, S. Isaacson, R. Yanagihara, and D. C. Gajdusek. 1996. Heightened expression of tumor necrosis factor alpha, interleukin-1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc. Natl. Acad. Sci. USA 93:9754-9758.
19. Lasmezas, C. I., J. P. Deslys, O. Robain, A. Jaegly, V. Beringue, J. M. Peyrin, J. G. Fournier, J. J. Hauw, J. Rossier, and D. Dormont. 1997. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402-405.
20. Manuelidis, E. E., E. J. Gorgacs, and L. Manuelidis. 1978. Viremia in experimental Creutzfeldt-Jakob disease. Science 200:1069-1071.
21. Manuelidis, L. 1994. The dimensions of Creutzfeldt-Jakob disease. Transfusion 34:915-928.
22. Manuelidis, L, 1998. Vaccination with an attenuated Creutzfeldt-Jakob disease strain prevents expression of a virulent agent. Proc. Natl. Acad. Sci. USA 95:2520-2525.
23. Manuelidis, L., and W. Fritch. 1996. Infectivity and host responses in Creutzfeldt-Jakob disease. Virology 216:46-59.
24. Manuelidis, L., W. Fritch, and Y. G. Xi. 1997. Evolution of a strain of CJD that induces BSE-like plaques. Science 277:94-98.
25. Manuelidis, L., W. Fritch, and L Zaitsev. 1998, Dapsone to delay symptoms in Creutzfeldt-Jakob disease. Lancet 352:456.
26. Manuelidis, L., T. Sklaviadis, A. Akowitz, and W. Fritch. 1995. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 92:5124-5128.
27. Manuelidis, L., T. Sklaviadis, and E. E. Manuelidis. 1987. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J. 6:341-347.
28. Manuelidis, L., I. Zaitsev, P. Koni, Z. Y. Lu, R. A. Flavell, and W. Fritch. 2000. Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease. J. Virol. 74:8614-8622.
29. Martin, J., C. C. LaBranche, and F. Gonzalez-Searano. 2001. Differential, CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate. J. Virol. 75:3568-3580.
30. McCarthy, K., and J. de Vellis. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:890-902.
31. Merz, G. S., V. Schwenk, G. Schuller-Levis, S. Gruca, and H. M. Wisniewski. 1987. Isolation and characterization of macrophages from scrapie-infected mouse brain. Acta Neuropathol. 72:240-247.
32. Muhl, H., and C. A. Dinarello. 1997. Macrophage inflammatory protein-1 alpha production in lipopolysaccharide-stimulated human adherent blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine. J. Immunol. 159:5063-5069.
33. Murphy, G. M. J., L. Yang, and B. Cordell. 1998. Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J. Biol. Chem. 273:20967-20971.
34. Radebold, K., M. Chernyak, D. Martin, and L. Manuelidis. 2001. Bloodborne transit of CJD from brain to gut at early stages of infection. BMC Infect. Dis. 1:20.
35. Raeber, A. J., M. A. Klein, R. Frigg, E. Flechsig, A. Aguzzi, and C. Weissmann. 1999. PrP-dependent association of prions with splenic but not circulating lymphocytes of scrapie-infected mice. EMBO J. 18:2702-2706.
36. Riemer, C., I. Queck, D. Simon, R. Kurth, and M. Baier. 2000. Identification of upregulated genes in scrapie-infected brain tissue. J. Virol. 74:10245-10248.
37. Riesner, D., K. Kellings, K. Post, H. Wille, H. Serban, D. Groth, M. A. Baldwin, and S. B. Prusiner. 1996. Disruption of prion rods generates 10-nm spherical particles having high α-helical content and lacking scrapie infectivity. J. Virol. 70:1714-1722.
38. Sakaguchi, H., M. Takeya, H. Suzuki, H. Hakamata, T. Kodama, S. Horiuchi, S. Gordon, L. J. van der Laan, G. Kraal, S. Ishibashi, N. Kitamura, and K. Takahashi. 1998. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab. Investig. 78:423-434.
39. Schlomchik, M. J., K. Radebold, N. Duclos, and L. Manuelidis. 2001. Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells. Proc. Natl. Acad. Sci. USA 98:9289-9294.
40. Sica, A., A. Saccani, A. Borsatti, C. A. Power, T. N. Wells, W. Luini, N. Polentarutti, S. Sozzani, and A. Mantovani. 1997. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 185:969-974.
41. Sklaviadis, T. K., L. Manuelidis, and E. E. Manuelidis. 1989. Physical properties of the Creutzfeldt-Jakob disease agent. J. Virol. 63:1212-1222.
42. Somerville, R. A., R. C. Oberthur, U. Havekost, F. MacDonald, D. M. Taylor, and A. G. Dickinson. 2002. Characterization of thermodynamic diversity between transmissible spongiform encephatopathy agent strains and its theoretical implications. J. Biol. Chem. 277:11084-11089.
43. Tan, J., T. Town, D. Paris, T. Mori, Z. Suo, F. Crawford, M. P. Mattson, R. A. Flavell, and M. Mullan. 1999. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 286:2352-2355.
44. Telling, G. C., P. Parchi, S. J. DeArmond, P. Cortelli, P. Montagna, R. Gabizon, J. Mastrianni, E. Lugaresi, P. Gambetti, and S. B. Prusiner. 1996. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079-2082.
45. Thackray, A. M., and R. Bujdoso. 2002. PrPc expression influences the establishment of herpes simplex virus type I latency. J. Virol. 76:2498-2509.
46. Williams, A. E., A. Van Dam, D. Ritchie, P. Eikelenboom, and H. Fraser. 1994. Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the central nervous system during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res. 754:171-180.
47. Zielasek, J., and H. P. Hartung. 1996. Molecular mechanisms of microglial activation. Adv. Neuroimmunol. 6:191-222.